NIH-funded research R01 grant

Hormone receptor in artery muscle linked to obesity-related artery stiffness

Official title: Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular Stiffness

Funded at Tufts Medical Center · NIH-11248857 · Data updated 2026-11-12

This project explores how a hormone-activated receptor in artery muscle cells may make large blood vessels stiffer in people with obesity and how those effects differ between women and men.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTufts Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 5, 2014
Project endNovember 30, 2028
Funding year2026
Award (this year)$729,769
NIH project number5R01HL119290-10
Project IDNIH-11248857 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity (elevated BMI), especially women, or adults willing to donate vascular tissue or take part in hospital-based vascular studies would be most relevant.

Less likely to help

People without obesity or whose vascular problems stem from other causes may not receive direct benefit from this work.

What this research studies

Researchers will study the mineralocorticoid receptor (MR) in vascular smooth muscle cells using mice fed a high-fat diet and human aortic muscle cells from donors to compare obese versus lean conditions. They will compare males and females to identify sex-specific pathways that drive artery stiffening. The work examines the role of fat around blood vessels (perivascular adipose tissue), oxidative stress, HIF1α, and an MR isoform in promoting stiffness and uses measures of aortic stiffness and cellular assays. The team will test whether removing or blocking MR in artery muscle cells protects vessels from stiffening and look for molecular markers that could guide future treatments.

Why it matters

Potential benefit: If successful, this work could point to sex-specific ways to prevent or reverse artery stiffening in people with obesity, reducing risks of high blood pressure, heart attack, and stroke.

How similar studies have gone: Prior animal studies and early data from human artery cells suggest targeting smooth-muscle MR can reduce vessel stiffening, but benefits in people are not yet proven.

Where this research is happening

  • Tufts Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Jaffe, Iris Z — Tufts Medical Center
  • Study coordinator: Jaffe, Iris Z

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.